Bio-Path Holdings Inc (BPTH)
3.23
+0.18
(+5.90%)
USD |
NASDAQ |
Apr 17, 16:00
3.00
-0.23
(-7.12%)
After-Hours: 17:59
Bio-Path Holdings Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 20.01M |
September 30, 2021 | 24.30M |
June 30, 2021 | 22.90M |
March 31, 2021 | 22.90M |
December 31, 2020 | 4.289M |
September 30, 2020 | 7.289M |
June 30, 2020 | 7.458M |
March 31, 2020 | 7.503M |
December 31, 2019 | 27.78M |
September 30, 2019 | 20.50M |
June 30, 2019 | 21.50M |
March 31, 2019 | 21.46M |
December 31, 2018 | 1.18M |
September 30, 2018 | 4.746M |
June 30, 2018 | 3.537M |
March 31, 2018 | 5.085M |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 |
Date | Value |
---|---|
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 14.25M |
September 30, 2014 | 13.74M |
June 30, 2014 | 16.63M |
March 31, 2014 | 18.84M |
December 31, 2013 | 5.331M |
September 30, 2013 | 6.030M |
June 30, 2013 | 3.852M |
March 31, 2013 | 1.856M |
December 31, 2012 | 1.600M |
September 30, 2012 | 1.473M |
June 30, 2012 | 0.9021M |
March 31, 2012 | 1.399M |
December 31, 2011 | 2.034M |
September 30, 2011 | 1.873M |
June 30, 2011 | 1.903M |
March 31, 2011 | 1.535M |
December 31, 2010 | 1.049M |
September 30, 2010 | 1.309M |
June 30, 2010 | 1.138M |
March 31, 2010 | 0.9405M |
December 31, 2009 | 0.7376M |
September 30, 2009 | 0.1187M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.289M
Minimum
Dec 2020
27.78M
Maximum
Dec 2019
16.95M
Average
20.50M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |